BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 91 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $41,000 | +241.7% | 31,415 | +175.2% | 0.01% | +150.0% |
| Q3 2019 | $12,000 | -36.8% | 11,415 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $19,000 | -50.0% | 11,415 | 0.0% | 0.00% | -60.0% |
| Q1 2019 | $38,000 | -74.7% | 11,415 | -77.8% | 0.01% | -79.2% |
| Q4 2018 | $150,000 | -51.5% | 51,415 | +2.6% | 0.02% | -42.9% |
| Q3 2018 | $309,000 | -17.2% | 50,115 | -0.9% | 0.04% | -22.2% |
| Q2 2018 | $373,000 | +14.4% | 50,545 | +1.7% | 0.05% | +10.2% |
| Q1 2018 | $326,000 | -19.7% | 49,685 | +2.9% | 0.05% | -19.7% |
| Q4 2017 | $406,000 | +185.9% | 48,285 | +293.0% | 0.06% | +165.2% |
| Q3 2017 | $142,000 | -55.1% | 12,285 | -52.0% | 0.02% | -58.9% |
| Q1 2017 | $316,000 | – | 25,585 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 220,000 | $5,069,000 | 3.43% |
| Perceptive Advisors | 1,046,402 | $24,109,000 | 2.02% |
| Redmile Group, LLC | 860,809 | $17,269,000 | 1.88% |
| Baker Brothers Advisors | 4,283,732 | $98,697,000 | 1.01% |
| RA Capital Management | 1,026,402 | $9,337,000 | 1.00% |
| Ghost Tree Capital, LLC | 75,000 | $1,728,000 | 0.83% |
| ACUTA CAPITAL PARTNERS, LLC | 45,750 | $1,054,000 | 0.71% |
| GREAT POINT PARTNERS LLC | 50,000 | $1,152,000 | 0.55% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 167,210 | $3,853,000 | 0.33% |
| EMERALD ADVISERS, LLC | 198,202 | $4,567,000 | 0.24% |